Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 121-140 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 121 | Azista Industries Private Limited lowweak | Opp 3 Risk 2 | Thesis: Reviewed evidence rationale says Azista Industries successfully imaged the ISS using its AFR satellite and notes potential uses in space situational awareness and missile monitoring. If current, successful imaging and dual-use application potential support a modest 1 year+ opportunity case. Why now: The only support cited is article in the membership rationale. Because the company coverage report shows zero articles after recent evidence window and zero evidence after recent evidence window, there is no robust timing catalyst beyond the historical demonstration narrative. Caveats: Single-article support only, and not available as active evidence. No direct evidence on customer conversion, regulatory adoption, or funding. Private-company visibility is limited in these reviewed sources. |
| 122 | Bellatrix Aerospace lowweak | Opp 3 Risk 2 | Thesis: Reviewed evidence membership rationale describes Bellatrix Aerospace as a space propulsion company partnering on a VLEO satellite mission using its air-breathing electric propulsion platform. If current, that points to differentiated technology and a potentially durable 1-year-plus opportunity setup, but the reviewed sources lack citeable direct evidence or article. Why now: Why now is only moderate in theory because propulsion/platform partnerships can matter over a 1-year-plus horizon, but these reviewed sources does not provide recency-anchored evidence after recent evidence window. Caveats: No direct evidence with available for citation. Technology differentiation is only inferred from membership rationale and is not independently corroborated in available evidence. |
| 123 | D-Orbit lowweak | Opp 3 Risk 2 | Thesis: D-Orbit appears strategically positioned in space logistics and in-orbit servicing, with reviewed sources rationale referencing an ESA award and supporting context noting prior Series D funding, but the retained in-window evidence is weak and mostly undated context. Why now: Why-now is weak because retained evidence after recent evidence window is mostly undated context; one cited article is from February 14, 2026 and therefore outside the 90-day evidence window, while the remaining available context is undated. Evidence
Caveats: Reviewed evidence membership rationale mentions a €119 million ESA contract, but no citeable retained row for that contract is included here. Series D funding mention is in a February 14, 2026 article outside the 90-day recent evidence window. Undated context is not recency proof. |
| 124 | Fujitsu lowweak | Opp 3 Risk 1 | Thesis: Fujitsu has a plausible long-horizon opportunity angle because the reviewed sources' membership rationale says it signed an MOU with BULL to develop a high-precision space situational awareness service for Japan. That suggests direct participation in an SDA-related service, but the reviewed sources still frames Fujitsu primarily as a large IT/services company and provides no direct positive evidence row or after recent evidence window (: and; not provided in reviewed sources). Why now: An MOU in SDA could matter over a 1 year+ horizon if it converts into deployments or service revenue, but the reviewed sources offers no direct dated evidence inside recent evidence window and no article to validate timing. Caveats: Large diversified company; reviewed sources does not show materiality of space effort. MOU is weaker than signed commercial contract revenue evidence. No direct article content or is available in reviewed sources. |
| 125 | GalaxySpace lowweak | Opp 3 Risk 2 | Thesis: GalaxySpace has some strategic optionality because the reviewed sources say it set up a space computing research institute and places it in space computing and satellite communications context, but that is early and not enough for a strong opportunity call. Why now: The reviewed sources references article: for the research institute setup, yet does not provide the article or direct event details to assess timing or commercial conversion. Caveats: Only one article is considered and no representative article object is provided. Research institute formation is weaker than product, contract, or financing milestones. Commercial impact timing is unclear. |
| 126 | Gate Space lowweak | Opp 3 Risk 2 | Thesis: Gate Space has a modest opportunity case because an undated supporting article context item says it won 6.3 million euros in funding from a government-backed accelerator program, which could support longer-horizon development if still current Why now: For a 1 year+ horizon, funding can matter, but recency is uncertain because the article is explicitly undated and the reviewed sources say undated external evidence is relevance context rather than recency proof Evidence
Caveats: The evidence is weak context and supporting article context, not direct structured company event/fact evidence. The article is undated; the reviewed sources explicitly says recency-sensitive claims should be treated cautiously. Same-article repeated rows are not independent confirmation. |
| 127 | Globalstar lowweak | Opp 3 Risk 4 | Thesis: Globalstar's cohort fit as a satellite communications and direct-to-device company is clear from the membership rationale, but these reviewed sources provide no in-window direct evidence to support a stronger opportunity ranking. Why now: There is effectively no why-now evidence in this row: the recent evidence review shows zero kept rows after the March 29, 2026 cutoff and no representative articles are provided. Caveats: The phase-2 rationale mentions Amazon acquisition-related articles, but those supporting articles are not included in the available evidence for this row. Scores remain low because absence of evidence is not positive evidence. |
| 128 | Goonhilly Earth Station Ltd lowweak | Opp 3 Risk 3 | Thesis: Among this screen, Goonhilly has the strongest stated strategic relevance because the reviewed sources' membership rationale says it has ground-station/COMSAT revenue and is involved in a transaction with Intuitive Machines, implying potentially durable space-infrastructure relevance over a 1 year+ horizon. However, the reviewed sources provide no retained direct evidence or article summaries to verify timing or terms, so the opportunity case remains weak. Why now: The only 'why now' available is the reviewed sources' statement that Goonhilly is being acquired by Intuitive Machines, cited in phase-2 support, and: but no, timestamps, or retained evidence are provided, so recency and sequence cannot be validated. Caveats: The reviewed sources rationale states Goonhilly has ground-station/COMSAT revenue and is being acquired by Intuitive Machines, tied to, and: but no or retained evidence are present. Coverage debug still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Because chronology cannot be verified, transaction-state claims should be treated cautiously. |
| 129 | GS Yuasa Corporation lowweak | Opp 3 Risk 1 | Thesis: GS Yuasa has the cleanest stated product adjacency in the reviewed sources because the membership rationale says it is listed as a key player in a space battery market report. If that positioning reflects real participation in spacecraft power systems, it could matter over a 1 year+ horizon; however, the reviewed sources provide no retained direct evidence or dated summaries, so the opportunity score remains modest. Why now: There is no verified near-term catalyst, but the reviewed sources' phase-2 rationale references saying GS Yuasa was named as a key player in a space battery market report. Without, timing detail, or retained evidence, recency is uncertain. Caveats: The rationale cites, but no or retained article text is provided. Being listed as a key player in a market report is weaker than direct contract, launch, or financial evidence. No retained evidence remain after the 90-day recent evidence window. |
| 130 | HEO lowweak | Opp 3 Risk 2 | Thesis: Possible long-horizon opportunity from being listed as operating and from an undated mention of a seven-figure BlackSky space domain awareness expansion contract for automated non-Earth imaging missions, but this is only supporting article context and recency is uncertain. Why now: Why now is weak because both cited items are undated, so the reviewed sources does not establish a fresh catalyst within the current evidence window. The only support is that HEO appears in current reviewed sources context as an operating company and as associated with a contract mention, but recency cannot be confirmed from the reviewed sources Evidence
Caveats: Both supporting items are undated, so recency is uncertain. Support is supporting article context, not stronger company-specific dated event evidence. Same-article repeated rows in the reviewed sources are not independent confirmation. |
| 131 | Hula Earth lowweak | Opp 3 Risk 1 | Thesis: There is a weak, article-level opportunity case that Hula Earth is an early-stage biodiversity monitoring platform using satellite imagery and that it had raised seed funding by the time of the cited profile, which could support long-horizon company development. However, this is not direct event/fact evidence in the reviewed sources; it is external article context only. Why now: The only dated retained context is a Startup Intros profile with April 16, 2026, stating Hula Earth uses IoT sensors and satellite imagery and had raised €1.6 million in seed funding; that is recent enough for a 1 year+ watchlist but too weak for a high-conviction thesis. Evidence
Caveats: Evidence is weak context and supporting article context, not direct company event/facts. The funding itself is described as having occurred in November 2024 inside an April 16, 2026 profile, so exact recency of the financing event is older than the profile date. Reviewed evidence itself says Earth observation fit is plausible but not strong from these reviewed sources alone. |
| 132 | HyPrSpace lowweak | Opp 3 Risk 4 | Thesis: HyPrSpace has some long-horizon upside as a launch startup because the reviewed sources membership rationale says it raised a €21M Series A and is developing hybrid propulsion for a small launch vehicle and suborbital prototype. Why now: The reviewed sources does not provide recent evidence window-supported article details for the cited raise and development milestones, so the timing case is under-evidenced. Caveats: No representative articles or direct evidence are available after recent evidence filtering. The opportunity view rests only on the membership rationale rather than article-level evidence available for citation. |
| 133 | Institute for Q-shu Pioneers of Space, Inc (iQPS) lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources say iQPS is a private Japanese Earth-imaging company whose QPS-SAR satellites are launched on Rocket Lab missions. That indicates a functioning path to deployment and a potentially scalable SAR imaging platform over a 1 year+ horizon. Why now: Why now is only modest because launch-linked deployment could matter over a long horizon, but there are no available article summaries or dated events to establish current momentum. Caveats: Membership rationale references article IDs and, but no or summaries are provided. No direct evidence survived or were available into these reviewed sources after recent evidence window. Do not use relation context as counterparty propagation evidence. |
| 134 | IonQ lowweak | Opp 3 Risk 3 | Thesis: IonQ has a possible strategic long-horizon opportunity if the reviewed sources' referenced Capella Space subsidiary linkage and SDA prototype agreement ultimately create material space exposure, but the reviewed sources does not allow straightforward propagation from subsidiary or relation context to IonQ itself without stronger direct evidence. Why now: Potential 'why now' would be the referenced space-subsidiary contract pathway, but recency and direct materiality to IonQ are not validated in available evidence for the 90-day recent evidence window. Caveats: Phase-2 rationale references and: but no or summaries are provided in the reviewed sources. Relations and counterparty propagation are not allowed by default. Coverage debug shows zero evidence after recent evidence window despite a large article universe. |
| 135 | ispace lowweak | Opp 3 Risk 4 | Thesis: The reviewed sources places ispace in private lunar mission context and notes 'ispace Hakuto-R,' which indicates continuing relevance in lunar mission execution if the program remains active. Why now: The membership support cites: and: The reviewed sources' wording around a second attempt makes mission outcome and execution durability relevant over a 1 year+ horizon, but timing confidence is reduced because no evidence survived into the available set. Caveats: Risk thesis is inferred from reviewed sources rationale mentioning a prior failure, not from available direct negative evidence. No direct evidence confirms current mission status, financing, or customer pipeline. Recency and sequencing of mission milestones cannot be validated from the empty evidence table. |
| 136 | Kepler Aerospace lowweak | Opp 3 Risk 3 | Thesis: Reviewed evidence context describes Kepler Aerospace as an Indian New Space startup operating a GSaaS network, integrating ground stations, and working on CubeSat platforms and satellite communications infrastructure. That breadth could support a 1 year+ infrastructure thesis, but there is no available in-window evidence of contracts, deployments, or financing progress. Why now: No current catalyst is established. Membership support references article ID: but the reviewed sources provide no and shows no evidence after recent evidence window. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article ID: but the reviewed sources provide no or article summary. Context includes relation/fact counts in support statistics, but relations are context-only and cannot be propagated as operating proof. |
| 137 | Kepler Communications lowweak | Opp 3 Risk 2 | Thesis: The reviewed sources places Kepler Communications in space communications, HydRON network or optical communications context, and also notes it as an Nvidia space-AI customer. If accurate and current, those references could support a strategic network and onboard compute opportunity over 1 year+. Why now: The reviewed sources references, and: in membership support, suggesting recent strategic context, but no post-recent evidence window evidence are actually available for scoring. Caveats: Reviewed evidence itself says support is somewhat contextual. Context-only references are weaker than direct event/fact evidence. No available evidence confirms deployment, revenue, or funding milestones. |
| 138 | LiveEO lowweak | Opp 3 Risk 2 | Thesis: Reviewed evidence rationale says LiveEO secured ESA funding for the Twinspector satellite constellation for infrastructure monitoring, which could support a 1 year+ commercialization path, but there is no directly citable within the recent evidence window evidence in the reviewed sources. Why now: Why-now cannot be established because no evidence remain after recent evidence filtering. Caveats: Phase2 membership rationale references, but no summary or evidence are provided for citation. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low scores reflect missing usable evidence, not a bearish business judgment. |
| 139 | Mach Industries lowweak | Opp 3 Risk 2 | Thesis: Among this screen, Mach Industries has one of the stronger but still weakly grounded setups because the reviewed sources' membership rationale says it is a startup that raised $300 million and builds aerospace/defense systems including a 'Stratos satellite platform.' If accurate, that suggests longer-horizon capital availability and product ambition, but the reviewed sources provide no direct positive evidence row or after recent evidence window to validate scale, timing, or execution (: not provided in reviewed sources). Why now: For a 1 year+ horizon, a large raise and mention of a satellite platform could matter if recent, but the reviewed sources does not provide usable dated evidence within the 90-day recent evidence window and explicitly reports zero available evidence after recent evidence window. Caveats: No article provided in reviewed sources. No direct event/facts are available after recent evidence window despite the membership rationale referencing a raise. Primarily defense-tech framing may limit pure-play space thesis relevance. |
| 140 | Maxar Technologies Inc. lowweak | Opp 3 Risk 2 | Thesis: Maxar has some residual opportunity appeal because the membership rationale cites a specific $500 million NASA deal in a commercial satellite imaging market report, which would be material if current, but the reviewed sources includes no retained evidence row or recent article summary to validate status or timing now. Why now: No retained evidence is available within the reviewed sources despite the membership rationale referencing a prior NASA deal article. That makes the name a weak current candidate under local-evidence-only rules. Caveats: No retained article summary or dated event row is provided for the cited NASA deal. Cannot elevate conviction based only on membership rationale. |
Risk view
Showing rows 341-360 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 341 | Nanoracks lowweak | Opp 2 Risk 1 | Thesis: No retained adverse evidence is provided. The main risk is evidentiary staleness rather than a documented business problem. Why now: There is no valid within the recent evidence window catalyst. The only company-specific article is at with September 2, 2025, and the reviewed sources say it was excluded by the 90-day cutoff. Evidence
Caveats: The only cited article is outside the selected 90-day evidence recent evidence window and therefore should not drive strong ranking. This is supporting source context, not merged serving evidence. No retained direct positive or negative evidence remain after recent evidence window. |
| 342 | NeevCloud lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supportable because no direct negative evidence survived the 90-day recent evidence window in the retained reviewed sources. Why now: Why now is weak: despite membership rationale referring to partnerships and orbital data center / AI inferencing context, the retained reviewed sources contain zero evidence after recent evidence window and no citable article summaries. Caveats: Phase-2 membership rationale references, and: but no summaries or direct evidence are retained here for factual claims. The reviewed sources itself says NeevCloud is space-adjacent and not clearly a qualifying space company. |
| 343 | NewOrbit lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources. Why now: No retained post-recent evidence window evidence are available, so current timing cannot be established from these reviewed sources. Caveats: Only membership rationale supports the company in this screen. No citeable retained evidence after recent evidence window. |
| 344 | OHB SE lowweak | Opp 1 Risk 1 | Thesis: No within the recent evidence window direct negative evidence was available, so there is insufficient reviewed sources support to form a material adverse thesis. Why now: There is no retained article or evidence row after the 90-day recent evidence window for OHB SE; recency-based ranking is therefore not supported by the reviewed sources. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Phase-2 cohort membership rationale is not directional evidence and cannot substitute for retained article evidence. Because no article were retained after recent evidence window, no company-specific factual thesis can be cited from these reviewed sources. |
| 345 | Optimized Electrotech Pvt Ltd lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window direct negative evidence was available, so a material risk thesis is not supported. Why now: No retained company evidence after the 90-day recent evidence window means there is no evidence-set-backed timing reason to rank this name higher now. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites article IDs, and, but no or retained evidence text are available here. Without retained article evidence, absence of bad news is not positive evidence. |
| 346 | OrbitOn lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is present, but because the only cited evidence is an older database-style listing that falls outside the recent evidence window, current execution and business-state risk cannot be assessed confidently. Why now: Why now is weak because the only visible article has March 4, 2025 on a source date basis and the reviewed sources report no current evidence was retained after the March 29, 2026 cutoff Evidence
Caveats: Only article detail shown is outside the 90-day recent evidence window and was dropped. Database/listing style evidence is weaker than company-specific event evidence. External supporting source context is relevance context, not stronger than direct retained evidence. |
| 347 | Paras Defence and Space Technologies Ltd lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supported within the reviewed sources' 90-day evidence window. Risk is low-scored because evidence is absent, not because business risk is disproven. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Paras Defence and Space Technologies Ltd. Caveats: Phase-2 membership rationale references article, but the reviewed sources does not provide or quoted evidence for that item, so it cannot be used as a factual directional citation. No direct positive or negative evidence survived the 90-day recent evidence window. |
| 348 | Parsons Corporation lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window. Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Parsons Corporation. Caveats: Phase-2 membership rationale references articles: and, but the reviewed sources provide no for citation. Article-level market-report inclusion is weaker than direct company-specific operating evidence. |
| 349 | PhysicsX lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is retained, so there is no supported material risk thesis either. Why now: There is no current catalyst evidence because articles after recent evidence window = 0 and evidence after recent evidence window = 0. Caveats: Funding-round context in rationale lacks -cited retained evidence here. Space relevance is explicitly weak in the reviewed sources rationale. |
| 350 | PierSight lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is supplied after recent evidence filtering, so a risk thesis is also not supported. Why now: Why now is unsupported because the reviewed sources show no surviving evidence after recent evidence filtering; there is no direct dated milestone or problem signal to anchor a 1 year+ thesis. Caveats: Only membership-level rationale is present; no citable evidence survived. No direct company-specific positive or negative events are available in the reviewed sources. Low scores reflect evidence scarcity. |
| 351 | Pilot Photonics lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is available; the main risk is that the reviewed sources lack retained direct evidence on timing, follow-on awards, or commercial conversion beyond the cited membership rationale. Why now: Why now is limited because only membership rationale references article: and the reviewed sources provide no or retained evidence after recent evidence window. Caveats: The ESA contract claim cannot be elevated strongly without the underlying article or summary in the reviewed sources. Coverage data shows evidence after recent evidence window 0. Opportunity may be real, but reviewed sources support is too sparse for higher conviction. |
| 352 | Pixxel lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources contain no retained adverse evidence within the recent evidence window, so there is no evidence-based risk thesis beyond execution uncertainty from being a private space startup with limited current reviewed sources support. Why now: Why now is weak because the only cited article summary in the reviewed sources are outside the 90-day evidence window, October 13, 2025 Caveats: The representative article for Pixxel is outside the recent evidence window and evidence recent evidence review shows kept_rows 0. No retained structured positive or negative rows are available. |
| 353 | Pixxel lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained, so there is no evidence-based negative thesis in these reviewed sources version. Why now: Why now is weak because no articles or evidence were retained after the March 29, 2026 cutoff in these reviewed sources version. Caveats: Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Membership rationale references article IDs without, which cannot be cited as factual support here. |
| 354 | Portal Space Systems lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window negative evidence was available, so the reviewed sources does not support a material risk view. Why now: There is no retained evidence inside the 90-day recent evidence window, so no current catalyst or business-state update is citable from these reviewed sources. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article IDs, and, but no or retained summaries are supplied. Low score reflects lack of citable evidence, not a negative business judgment. |
| 355 | Precursor SPC lowweak | Opp 1 Risk 1 | Thesis: No material negative thesis is supportable from retained evidence in these reviewed sources. Why now: Why now is weak because the reviewed sources show no available post-recent evidence window evidence; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0. Caveats: Phase-2 rationale references without or retained evidence detail, so it is not sufficient for factual grounding here. No direct positive or negative evidence arrays are populated. Low scores are an evidence-gap judgment, not a business conclusion. |
| 356 | Quantum Opus lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supported because the reviewed sources contain no direct negative evidence within the recent evidence window. Why now: There is no clear why-now catalyst because coverage after the 90-day recent evidence window is empty. Caveats: Membership support exists but no representative article is provided for. No retained evidence after recent evidence window. No direct business-state update, financing, contract, or customer traction evidence is available. |
| 357 | Quantum Systems GmbH lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available. The reviewed sources does not provide material adverse company-specific facts within the recent evidence window. Why now: There is no supported near-term or long-horizon catalyst in the reviewed sources because zero post-recent evidence window evidence were available. Caveats: Phase2 rationale references article IDs: and: as article context only, but no were provided in the reviewed sources. Coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Context-only mentions and portfolio references cannot substitute for direct positive or negative evidence. |
| 358 | Rogers Communications Inc. lowweak | Opp 1 Risk 1 | Thesis: No material adverse thesis is supported by the reviewed sources. Risk is scored low only because evidence is absent, not because the company is de-risked. Why now: There is no available 90-day evidence for Rogers in these reviewed sources; coverage data shows zero article ids after recent evidence window and zero evidence after recent evidence window, so there is no supported 'why now' catalyst in the provided evidence. Caveats: No direct positive or negative evidence were available after the 90-day recent evidence window for Rogers. Phase2 rationale references support references including: but no article or article summary for that item is included in these reviewed sources, so it cannot be cited as factual evidence. Opportunity score is kept near zero because the evidence standard require positive evidence, not mere absence of risk. |
| 359 | Rogue Space Systems lowweak | Opp 2 Risk 1 | Thesis: No material negative development is documented in the retained reviewed sources; the principal risk is low evidence quality and lack of dated corroboration. Why now: The only retained evidence is an undated external sector page listing Rogue Space Systems as an operating in-orbit servicing company, so the why-now is weak and recency is uncertain. Evidence
Caveats: Evidence is undated and explicitly not recency proof per reviewed sources policy. Same-article repeated rows are not independent confirmation. No direct evidence of contracts, funding, milestones, or setbacks is included. |
| 360 | Romanian InSpace Engineering lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available, so no supported risk thesis exists beyond sparse-coverage uncertainty. Why now: No why-now catalyst is evidenced because there are no retained 90-day evidence. Caveats: Reviewed evidence references but provides no. Single historical membership-support mention only. No retained evidence after recent evidence window. |